Literature DB >> 29685656

Synthesis, structure and bioactivity of primary sulfamate-containing natural products.

Prashant Mujumdar1, Silvia Bua2, Claudiu T Supuran2, Thomas S Peat3, Sally-Ann Poulsen4.   

Abstract

Here we report the synthesis of natural products (NPs) 5'-O-sulfamoyl adenosine 1 and 5'-O-sulfamoyl-2-chloroadenosine 2. As primary sulfamates these compounds represent an uncommon class of NPs, furthermore there are few NPs known that contain a NS bond. Compounds 1 and 2 were evaluated for inhibition of carbonic anhydrases (CA), a metalloenzyme family where the primary sulfamate is known to coordinate to the active site zinc and form key hydrogen bonds with adjacent CA active site residues. Both NPs were good to moderate CA inhibitors, with compound 2 a 20-50-fold stronger CA inhibitor (Ki values 65-234 nM) than compound 1. The protein X-ray crystal structures of 1 and 2 in complex with CA II show that it is not the halogen-hydrophobic interactions that give compound 2 a greater binding energy but a slight movement in orientation of the ribose ring that allows better hydrogen bonds to CA residues. Compounds 1 and 2 were further investigated for antimicrobial activity against a panel of microbes relevant to human health, including Gram-negative bacteria (4 strains), Gram-positive bacteria (1 strain) and yeast (2 strains). Antimicrobial activity and selectivity was observed. The minimum inhibitory concentration (MIC) of NP 1 was 10 µM against Gram-positive Staphylococcus aureus and NP 2 was 5 µM against Gram-negative Escherichia coli. This is the first time that NP primary sulfamates have been assessed for inhibition and binding to CAs, with systematic antimicrobial activity studies also reported.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antimicrobial; Carbonic anhydrase; Inhibitor; Natural product; Nucleoside; Sulfamate

Mesh:

Substances:

Year:  2018        PMID: 29685656     DOI: 10.1016/j.bmcl.2018.04.038

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  5 in total

Review 1.  Carbonic anhydrase XII inhibition overcomes P-glycoprotein-mediated drug resistance: a potential new combination therapy in cancer.

Authors:  Kathryn F Tonissen; Sally-Ann Poulsen
Journal:  Cancer Drug Resist       Date:  2021-06-19

2.  Reaction hijacking of tyrosine tRNA synthetase as a new whole-of-life-cycle antimalarial strategy.

Authors:  Stanley C Xie; Riley D Metcalfe; Steven P Langston; Lawrence R Dick; Michael D W Griffin; Alexandra E Gould; Leann Tilley; Elyse Dunn; Craig J Morton; Shih-Chung Huang; Tanya Puhalovich; Yawei Du; Sergio Wittlin; Shuai Nie; Madeline R Luth; Liting Ma; Mi-Sook Kim; Charisse Flerida A Pasaje; Krittikorn Kumpornsin; Carlo Giannangelo; Fiona J Houghton; Alisje Churchyard; Mufuliat T Famodimu; Daniel C Barry; David L Gillett; Sumanta Dey; Clara C Kosasih; William Newman; Jacquin C Niles; Marcus C S Lee; Jake Baum; Sabine Ottilie; Elizabeth A Winzeler; Darren J Creek; Nicholas Williamson; Michael W Parker; Stephen Brand
Journal:  Science       Date:  2022-06-02       Impact factor: 63.714

Review 3.  Synthetic approaches and pharmaceutical applications of chloro-containing molecules for drug discovery: A critical review.

Authors:  Wan-Yin Fang; L Ravindar; K P Rakesh; H M Manukumar; C S Shantharam; Njud S Alharbi; Hua-Li Qin
Journal:  Eur J Med Chem       Date:  2019-04-10       Impact factor: 6.514

4.  Isolation of 5'-O-sulfamyladenosine and related 3'-O-β-glucosylated adenosines from the nucleocidin producer Streptomyces calvus.

Authors:  Xuan Feng; Davide Bello; David O'Hagan
Journal:  RSC Adv       Date:  2021-01-28       Impact factor: 3.361

5.  Two 3'-O-β-glucosylated nucleoside fluorometabolites related to nucleocidin in Streptomyces calvus.

Authors:  Xuan Feng; Davide Bello; Phillip T Lowe; Joshua Clark; David O'Hagan
Journal:  Chem Sci       Date:  2019-08-20       Impact factor: 9.825

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.